PAS
CNMD icon

Park Avenue Securities’s CONMED CNMD Stock Holding History

Park Avenue Securities’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,951
Closed -$323K – 1366
2023
Q4 		$323K Buy
2,951
+242
+9% +$25K ﹤0.01% 1094
2023
Q3 		$273K Buy
+2,709
New +$311K ﹤0.01% 1095
2023
Q1 		– Sell
-2,675
Closed -$237K – 786
2022
Q4 		$237K Sell
2,675
-275
-9% -$22.8K ﹤0.01% 1074
2022
Q3 		$237K Buy
2,950
+222
+8% +$20.9K ﹤0.01% 1002
2022
Q2 		$261K Buy
2,728
+329
+14% +$39.5K 0.01% 974
2022
Q1 		$356K Buy
2,399
+276
+13% +$38.5K 0.01% 885
2021
Q4 		$301K Buy
+2,123
New +$301K 0.01% 917

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Park Avenue Securities's CNMD Position: Q1 2024 in Review

Park Avenue Securities sold out of CONMED (CNMD) in Q1 2024, closing a stake of 2,951 shares — an estimated $323K sold.

Park Avenue Securities first reported a position in CNMD in Q4 2021 and held it in 7 quarters. The position peaked at $356K in Q1 2022. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Park Avenue Securities reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Park Avenue Securities sold 2,951 CONMED shares in Q1 2024, an estimated $323K.
  • Park Avenue Securities first reported a position in CONMED in Q4 2021 and held it in 7 quarters.
  • Park Avenue Securities's CONMED position peaked at $356K in Q1 2022.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Park Avenue Securities's 13F filing for Q1 2024, filed 10 Apr 2024.